Fig. 2.
Neuromuscular blocking agents (NMBAs) implicated in anaphylaxis; suxamethonium: n = 12 (20%); rocuronium: n = 15 (25%); atracurium: n = 30 (49%); vecuronium: n = 4 (7%).
Neuromuscular blocking agents (NMBAs) implicated in anaphylaxis; suxamethonium: n = 12 (20%); rocuronium: n = 15 (25%); atracurium: n = 30 (49%); vecuronium: n = 4 (7%).